Preventing Medication-Related Problems in Care Transitions to Skilled Nursing Facilities

NCT05241951 — Not applicable, Completed, 1052 participants, University of Washington

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Preventing Medication-Related Problems in Care Transitions to Skilled Nursing Facilities Using a Pharmacy Integrated Transitional Team

RegistryNCT05241951
StatusCompleted
PhaseNot applicable
Study typeInterventional; randomized, crossover, masking: none, health services research
Enrollment1052 (Actual)
SponsorUniversity of Washington (Other); collaborators: Agency for Healthcare Research and Quality (AHRQ)
ConditionsCare Transition
InterventionsStructured hand-off, Medication reconciliation during transitional period, Transitional medication monitoring, Teleconsultation (Other)
Datesstart 2022-01-31, primary completion 2024-03-01, completion 2025-10-31, first posted 2022-02-16, last updated 2025-11-24
Locations1 site in United States

Related Papers Related Patents Related Grants Related Experts
All trials for Care Transition All trials of Structured hand-off All trials of Medication reconciliation during transitional period

-Summary

The Pharmacy Integrated Transitions (PIT) program, utilizes a crossover randomized control design to evaluate the impact of a clinical pharmacist in decreasing medication related problems during a patient's transition from hospital to skilled nursing facility (SNF).

Expand all sections  ·  Collapse all

+Detailed description

Standard hospital discharge processes (e.g. as recommended by the Joint Commission Center for Transforming Healthcare), include hospital staff completing a paper-based discharge summary and medication reconciliation form. To reduce the likelihood of medication-related problems during care transitions, the Pharmacy Integrated Transitions (PIT) program aims to improve the standard transition process by adding a coordinating transitional pharmacist to provide a structured synchronous "warm-handoff" between clinical teams at the hospital and the Skilled Nursing Facility, in addition to reconciling, adjusting, and monitoring medications during and after discharge from the hospital.

+Arms and interventions

ArmTypeInterventionsDescription
Clinical Pharmacist in Transition of CareExperimentalOther: Structured hand-off; Other: Medication reconciliation during transitional period; Other: Transitional medication monitoring; Other: TeleconsultationA clinical pharmacist will be provided as a patient discharges from one of four University of Washington (UW) medical centers to one of 14 post acute skilled nursing facilities randomized to the intervention arm. The coordinating transitional pharmacist will conduct (1) a comprehensive medication review including medication reconciliation, adjustment, and monitoring during the transitional period from hospital to SNF, 2) a structured handoff between clinical teams at the hospital and SNF.
Patient transitions from hospital to post-acute careNo interventionPatient will transition from one of four University of Washington (UW) medical centers to one of 14 post-acute skilled nursing facilities randomized to the control arm. Patients will receive the standard discharge process.
  • Structured hand-off (Other), also known as Standardized Checklist: Use of standardized checklist to provide synchronous or asynchronous handoff that conveys medication recommendations to the SNF clinical teams
  • Medication reconciliation during transitional period (Other): Comprehensive medication reconciliation conducted during transitional period between hospital and SNF, focused on SNF-specific requirements for medication delivery (e.g., stop dates, titration instructions)
  • Transitional medication monitoring (Other): Review of medication orders during first 7 days of SNF admittance to address barriers to translation of medication orders and appropriate medication delivery
  • Teleconsultation (Other): Ad hoc consultation to provide additional clarification to SNF clinical teams

+Outcome measures

Primary outcomes

  • Medication Related Problems [30 days post hospital discharge]: Number of medication related problems experienced by patients within 30 days post hospital discharge.

Secondary outcomes

  • Death [30 Days post hospital discharge]: Number of deaths experienced by patients within each cohort
  • Readmissions [30 Days]: Number of readmissions within 30 days of index hospital discharge

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

* 18 years of age and older
* patients receiving inpatient care at University of Washington Mountlake, University of Washington Northwest, Harborview, and Valley Medical Center hospitals to one of 14 collaborating SNF's on a day when the PIT program pharmacist is conducting the intervention

Exclusion Criteria:

* Under 18 years of age
* patients with a discharge on hospice care
* patients discharged on days that the pharmacist is not conducting the intervention

+Locations (1)

FacilityCityCountryStatus
University of Washington Health SystemSeattle, WashingtonUnited States

+Publications

  • Results publication: Hantouli MN, Monsell SE, Davidson GH, Chaing J, Comstock B, Dervish AA, Gionet NJ, Howard S, Jimenez N, Kim C, Liberman M, Lindo EG, Marcum ZA, Ong TD, Serrano E, Simons K, Sun LS, Zaslavsky O, Austin E; PIT Collaborative. Pharmacy Integrated Transitions (PIT) trial: a protocol for a pragmatic cluster-randomised crossover trial. BMJ Open. 2024 Dec 31;14(12):e088786. doi: 10.1136/bmjopen-2024-088786. PMID 39740951

+Investigators